睡眠時無呼吸装置の世界市場:治療機器、診断機器

◆英語タイトル:Sleep Apnea Devices Market Size, Share & Trends Analysis Report By Product [Therapeutic (PAP, Oral, Nasal, Chin), Diagnostic (Respiratory Polygraphs, Actigraph, Polysomnography, Pulse Oximeters)], By Region, 2019 - 2025
◆商品コード:GV9NV111
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2019年6月
◆ページ数:80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、睡眠時無呼吸装置の世界市場について調査・分析し、市場動向、製品別(治療機器、診断機器)分析、地域別分析、競合動向などを含め次の構成でお届け致します。

・調査手法及び範囲
・エグゼクティブサマリー
・市場動向
・睡眠時無呼吸装置の世界市場:製品別(治療機器、診断機器)
・睡眠時無呼吸装置の世界市場:地域別
・競合動向
【レポートの概要】

The global sleep apnea devices market size is estimated to be worth USD 12.61 billion by 2025, expanding at a CAGR of 6.8% from 2019 to 2025, according to a report by Grand View Research, Inc. Increasing number of patients suffering from sleep apnea, growing awareness, and treatment rate of these diseases in North America are some of the factors contributing to the revenue growth.

On the basis of product type, the market is categorized into therapeutic and diagnostic devices. Therapeutic device led the market with about 65.06% of revenue share in 2018, due to increased awareness and patient medication adherence in developed markets such as U.S. and Canada and high prevalence of Obstructive Sleep Apnea (OSA). PAP Devices led the therapeutic segment due to higher product adoption and availability and comparative higher patient outcome. The segment is expected to witness a CAGR of 5.1% between 2019 and 2025.

Diagnostic device segment comprises of actigraphs, polysomnography, respiratory polygraphs, and pulse oximeters. Polysomnography devices led the market with 34.88% of revenue share in 2018 and is estimated to witness a CAGR of 7.05% over the forecast period. As there is no gold standard for diagnosis of OSA, polysomnography is one of the most preferred diagnostic tests for sleep apnea. Increase in preference of polysomnography test is expected to drive the market revenue between 2019 and 2025.

Sleep apnea PAP devices have witnessed significant development in terms of design, safety, and efficacy has helped to boost product adoption and patient outcome. Moreover, miniaturization of PAP devices and availability of cheaper brands is expected to fuel growth of the sleep apnea devices market over the forecast period. Some of the key manufactur are BMC Medical Co. Ltd.; GE Healthcare; Fisher & Paykel Healthcare Limited; Curative Medical Inc.; Cadwell Laboratories ResMed; Invacare Corporation; Braebon Medical Corporation; ImThera Medical Inc.; Phillips Respironics; Curative Medical Inc.; Nihon Kohden; and Compumedics Limited.

Further key findings from the report suggest:

• Therapeutic devices segment led the market in 2018, with a revenue of USD 5,302.1 million, due to high prevalence of OSA, increased treatment rate, patient adherence, and availability of technologically advanced products

• Oral devices segment is anticipated to exhibit the fastest CAGR of 11.7% over the forecast period as these products offer higher patient outcome, lower economic burden, and higher treatment adherence due to their smaller size

• Some of the key players operating in the sleep apnea devices market are BMC Medical Co. Ltd.; GE Healthcare; Fisher & Paykel Healthcare Limited; Curative Medical Inc.; Cadwell Laboratories; ResMed; Invacare Corporation; Braebon Medical Corporation; ImThera Medical Inc.; Phillips Respironics; Curative Medical Inc.; Nihon Kohden; and Compumedics Limited

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Sleep Apnea Devices Market Outlook, By Revenue (USD Million)
2.2 Sleep Apnea Devices Market Segment Outlook, By Revenue (USD Million)
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Sleep Apnea Devices Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing prevalence of obstructive sleep apnea in chronic obstructive pulmonary disease (COPD)
3.2.1.2 Increasing prevalence of obesity and diabetes associated with sleep apnea
3.2.2 Market Restraint Analysis
3.2.2.1 High cost of diagnosis and treatment of sleep apnea
3.2.3 Penetration & Growth Prospect Mapping
3.2.4 Industry Analysis – Porter’s
3.2.4.1 Supplier Power
3.2.4.2 Buyer Power
3.2.4.3 Substitution Threat
3.2.4.4 Threat from new entrant
3.2.4.5 Competitive Rivalry
3.2.5 PESTEL Analysis
3.2.5.1 Political Landscape
3.2.5.2 Environmental Landscape
3.2.5.3 Social Landscape
3.2.5.4 Technology Landscape
3.2.5.5 Legal Landscape
3.2.6 Sleep Apnea Patient Pool
3.2.7 Sleep Apnea Devices: Product Adoption Analysis
3.2.8 Sleep Apnea Devices: Supply Chain Analysis
3.2.9 Case Studies (Business Model /Technology Adoption)
Chapter 4 Sleep Apnea Devices Market Estimates & Trend Analysis, by product type
4.1 Sleep Apnea Devices Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
4.2 Product Market Share Analysis, 2018
4.2.1 Therapeutic Devices
4.2.1.1 PAP Devices
4.2.1.2 Oral Devices
4.2.1.3 Nasal Devices
4.2.1.4 Chin Straps
4.2.2 Diagnostic Devices
4.2.2.1 Actigraphs
4.2.2.2 Polysomnography
4.2.2.3 Respiratory Polygraphs
4.2.2.4 Pulse Oximeters
4.3 Therapeutic Devices
4.3.1 PAP Devices
4.3.1.1 Global sleep apnea PAP device market, 2014 – 2025 (USD Million)
4.3 2 Oral Devices
4.3.1.1 Global sleep apnea oral devices market, 2014 – 2025 (USD Million)
4.3.3 Nasal Devices
4.3.1.1 Global sleep apnea nasal devices market, 2014 – 2025 (USD Million)
4.3.4 Chin Straps
4.3.1.1 Global sleep apnea chin straps market, 2014 – 2025 (USD Million)
4.4 Diagnostic Devices
4.4.1 Actigraphs
4.4.1.1 Global sleep apnea actigraphs market, 2014 – 2025 (USD Million)
4.4.2 Polysomnography
4.4.2.1 Global sleep apnea polysomnography market, 2014 – 2025 (USD Million)
4.4.3 Respiratory Polygraphs
4.4.3.1 Global sleep apnea respiratory polygraphs market, 2014 – 2025 (USD Million)
4.4.4 Pulse Oximeters
4.4.4.1 Global sleep apnea pulse oximeters market, 2014 – 2025 (USD Million)
Chapter 5 Sleep apnea devices Market: Regional Estimates & Trend Analysis, by Product
5.1 Regional Market Snapshot
5.2 Regional Market Share and Leading Players, 2018
5.2.1 North America
5.2.2 Europe
5.2.3 Asia Pacific
5.2.4 Latin America
5.2.5 Middle East & Africa
5.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.3.1 North America
5.3.2 Europe
5.3.3 Asia Pacific
5.3.4 Latin America
5.4.5 Middle East & Africa
5.4 Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:
5.4.1 North America
5.4.1.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.2 U.S.
5.4.2.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.3 Canada
5.4.3.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.4 Europe
5.4.4.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.5 UK
5.4.5.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.6 Germany
5.4.6.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.7 Spain
5.4.7.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.8 France
5.4.8.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.9 Italy
5.4.9.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.10 Russia
5.4.10.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.11 Asia Pacific
5.4.11.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.12 China
5.4.12.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.13 Japan
5.4.13.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.14 India
5.4.14.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.15 South Korea
5.4.15.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.16 Singapore
5.4.16.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.17 Australia
5.4.17.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.18 Latin America
5.4.18.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.19 Brazil
5.4.19.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.20 Mexico
5.4.20.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.21 Argentina
5.4.21.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.22 Middle East & Africa (MEA)
5.4.22.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.23 Tunisia
5.4.23.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.24 Egypt
5.4.24.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
5.4.25 South Africa
5.4.25.1 Market estimates and forecasts, by product 2014 – 2025 (USD Million)
Chapter 6 Competitive Landscape
6.1 Company Profiles
6.1.1 BMC Medical Co. Ltd.
6.1.1.1 Company overview
6.1.1.2 Financial Performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic Initiatives
6.2. Braebon Medical Corporation
6.2.1 Company overview
6.2.2 Financial Performance
6.2.3Product benchmarking
6.2.4 Strategic Initiatives
6.3. Carefusion Corp
6.3.1 Company overview
6.3.2 Financial Performance
6.3.3 Product benchmarking
6.3.4 Strategic Initiatives
6.4. Compumedics Limited
6.4.1 Company overview
6.4.2 Financial Performance
6.4.3 Product benchmarking
6.4.4 Strategic Initiatives
6.5. Curative Medical Inc.
6.5.1 Company overview
6.5.2 Financial Performance
6.5.3 Product benchmarking
6.5.4 Strategic Initiatives
6.6. Fisher & Paykel Healthcare
6.6.1 Company overview
6.6.2 Financial Performance
6.6.3 Product benchmarking
6.6.4 Strategic Initiatives
6.7. GE Healthcare
6.7.1 Company overview
6.7.2 Financial Performance
6.7.3 Product benchmarking
6.7.4 Strategic Initiatives
6.8. ImThera Medical Inc.
6.8.1 Company overview
6.8.2 Financial Performance
6.8.3 Product benchmarking
6.8.4 Strategic Initiatives
6.9. Invacare Corporation
6.9.1 Company overview
6.9.2 Financial Performance
6.9.3 Product benchmarking
6.9.4 Strategic Initiatives
6.10. Itamar Medical Ltd.
6.10.1 Company overview
6.10.2 Financial Performance
6.10.2 Product benchmarking
6.10.3 Strategic Initiatives
6.11. Natus Medical Inc.
6.11.1 Company overview
6.11.2 Financial Performance
6.11.3 Product benchmarking
6.11.4 Strategic Initiatives
6.12. Nihon Kohden
6.12.1 Company overview
6.12.2 Financial Performance
6.12.3 Product benchmarking
6.12.4 Strategic Initiatives
6.13. Philips Respironics
6.13.1 Company overview
6.13.2 Financial Performance
6.13.3 Product benchmarking
6.13.4 Strategic Initiatives
6.14. ResMed Inc.
6.14.1 Company overview
6.14.2 Financial Performance
6.14.3 Product benchmarking
6.14.4 Strategic Initiatives
6.15. Somnetics International Inc.
6.15.1 Company overview
6.15.2 Financial Performance
6.15.3 Product benchmarking
6.15.4 Strategic Initiatives
6.16. SOMNOmedics GmbH
6.16.1 Company overview
6.16.2 Financial Performance
6.16.3 Product benchmarking
6.16.4 Strategic Initiatives
6.17. Teleflex Inc.
6.17.1 Company overview
6.17.2 Financial Performance
6.17.3 Product benchmarking
6.17.4 Strategic Initiatives
6.18. Weinmann Medical Devices GmbH & Co. KG.
6.18.1 Company overview
6.18.2 Financial Performance
6.18.3 Product benchmarking
6.18.4 Strategic Initiatives

List of Tables

Table 1 Product pipeline analysis, by stage
Table 2 List of key End-users by region / by product / by country
Table 3 List of key distributors and channel partners
Table 4 List of key customers
Table 5 Competitive dashboard analysis
Table 6 List of key emerging companies/technology disruptors/innovators
Table 7 Supplier ranking
Table 8 Sleep apnea devices market, by type 2014 - 2025 (USD Million)
Table 9 North America sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 10 U.S. sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 11 Canada sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 12 Europe sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 13 UK sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 14 Germany sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 15 Spain sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 16 France sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 17 Italy sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 18 Russia sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 19 Asia Pacific sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 20 Japan sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 21 China sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 22 India sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 23 South Korea sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 24 Singapore sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 25 Australia sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 26 Latin America sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 27 Brazil sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 28 Mexico sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 29 Argentina sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 30 MEA sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 31 Tunisia sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 32 Egypt sleep apnea devices market, by Product type 2014 - 2025 (USD Million)
Table 33 South Africa sleep apnea devices market, by Product type 2014 - 2025 (USD Million)


【レポートのキーワード】

睡眠時無呼吸装置、治療機器、診断機器

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[睡眠時無呼吸装置の世界市場:治療機器、診断機器]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆